Acetylation of hydroxytyrosol enhances its transport across differentiated Caco-2 cell monolayers

Food Chemistry

Volumn 125, Issue 3, 2011, Pages 865-872

  Mateos, R ^a,b   Pereira Caro, G ^a,c   Saha, S ^a   Cert, R ^d   Redondo Horcajo, M ^e   Bravo, L ^b   Kroon, P A ^a  

^a NORWICH RESEARCH PARK   (United Kingdom)

^b INSTITUTO DEL FRÍO CSIC   (Spain)

^c IFAPA CENTRO EL TORUÑO   (Spain)

^d INSTITUTO DE LA GRASA   (Spain)

^e CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Antioxidants; Caco 2 cells; LC MS analysis; Metabolism; Phase 2 conjugation; Phenols; Trans epithelial transport

Indexed keywords

ACETYLATION; ANTIOXIDANTS; BIOACTIVITY; BIOMOLECULES; CYTOLOGY; INDIUM COMPOUNDS; METABOLISM; METABOLITES; MONOLAYERS; OLIVE OIL; PHENOLS; PHYSIOLOGY;

ANTIOXIDANT PROPERTIES; APPARENT PERMEABILITIES; CACO-2 CELLS; EPITHELIAL TRANSPORT; INTESTINAL ABSORPTION; INTESTINAL EPITHELIAL CELLS; LC-MS ANALYSIS; PHASE-2 CONJUGATION;

CELLS;

BETA GLUCURONIDASE; HYDROXYTYROSOL; HYDROXYTYROSYL ACETATE; PHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN CACO 2; CHEMICAL REACTION; DIODE; DIODE ARRAY DETECTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG METABOLISM; DRUG PENETRATION; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; INTESTINE EPITHELIUM CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SMALL INTESTINE ABSORPTION; SMALL INTESTINE MUCOSA;

EID: 78149416504     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2010.09.054     Document Type: Article

References (36)

1. Alcudia, F., Cert, A., Espartero, J.L., Mateos, R., & Trujillo, M. (2004). Method of preparing hydroxytyrosol esters, esters thus obtained and use of same. PCT WO 2004/005237.
2. Artursson P., Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophysical Research Communications 1991, 175:880-885.
3. Barrington R., Williamson G., Bennett R.N., Davis B.D., Brodbelt J.S., Kroon P.A. Absorption, conjugation and efflux of the flavonoides, kaempferol and galangin, using the intestinal Caco-2/TC7 cell model. Journal of Functional Foods 2009, 1(1):74-87.
4. Bendini A., Cerretani L., Carrasco-Pancorbo A., Gomez-Caravaca A.M. Phenolic molecules in virgin olive oils: A survey of their sensory properties, health effects, antioxidant activity and analytical methods. An overview of the last decade. Molecules 2007, 12:1679-1719.
5. Bogani P., Galli C., Villa M., Visioli F. Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis 2007, 190(1):181-186.
6. Bonifacio, M., & Soares-Da-Silva, P. (2004). Catechol-O-methyltransferase activity in Caco-2 cells. Conference Information: Annual Meeting of the American-Society-for-Cell-Biology, Meeting abstract 604, Molecular Biology of the cell, 15, 109A-109A.
7. Caruso D., Visioli F., Patelli R., Galli C., Galli G. Urinary excretion of olive oil phenols and their metabolites in humans. Metabolism, Clinical and Experimental 2001, 50:1426-1428.
8. Chen Y., Huang C., Zhou T., Chen G. Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells. Basic & Clinical Pharmacology & Toxicology 2008, 103:553-559.
9. Corona G., Tzonis X., Dessi M.A., Deiana M., Debnam E.S., Visioli F., et al. The fate of olive oil polyphenols in the gastrointestinal tract: Implications of gastric and colonic microflora-dependent biotransformation. Free Radical Research 2006, 40:647-658.
10. Covas M.I., de la Torre K., Farré-Albaladejo M., Kaikkonen J., Fitó M., López-Sabater C., et al. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radical Biology and Medicine 2006, 40:608-616.
11. Covas M.I., Nyyssonen K., Poulsen H.E., Kaikkonen J., Zunft H.J.F., Kiesewetter H., et al. The effect of polyphenols in olive oil on heart disease risk factors - A randomized trial. Annals of Internal Medicine 2006, 145(5):333-341.
12. Fernandez-Bolaños, J., Heredia, A., Rodríguez, G., Rodríguez, R., Jiménez, A., & Guillen, R. (2005). Methods for obtaining purified hydroxytyrosol from products and by-products derived from the olive tree. US 6849,770 B2.
13. Fito M., Cladellasc M., de la Torre R., Marti J., Alcantara M., Pujadas-Bastardes M., et al. Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: A randomized, crossover, controlled, clinical trial. Atherosclerosis 2005, 181:149-158.
14. Gregory P.A., Lewinsky R.H., Gardner-Stephen D.A., Mackenzie P.I. Coordinate regulation of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 genes by hepatocyte nuclear factor 1 alpha and the caudal-related homeodomain protein 2. Molecular Pharmacology 2004, 65:953-963.
15. Kaldas M.I., Walle K., Walle T. Resveratrol transport and metabolism by human intestinal Caco-2 cells. Journal of Pharmacy and Pharmacology 2003, 55:307-312.
16. Kern S.M., Bennett R.N., Needs P.W., Mellon F.A., Kroon P.A., Garcia-Conesa M.T. Characterization of metabolites of hydroxycinnamates in the in vitro model of human small intestinal epithelium Caco 2 cells. Journal of Agricultural and Food Chemistry 2003, 51:7884-7891.
17. Kroon P.A., Clifford M.N., Crozier A., Day A.J., Donovan J.L., Manach C., et al. How should we assess the effects of exposure to dietary polyphenols in vitro?. American Journal of Clinical Nutrition 2004, 80:15-21.
18. Leger C.L., Carbonneau M.A., Michel F., Mas E., Monnier L., Cristol J.P., et al. A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes. European Journal of Clinical Nutrition 2005, 59:727-730.
19. Liu X., Tam V.H., Hu M. Disposition of flavonoids via enteric recycling: Determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA. Molecular Pharmacology 2007, 4:873-882.
20. Manna C., Galletti P., Maisto G., Cucciolla V., D'Angelo S., Zappia V. Transport mechanism and metabolism of olive oil hydroxytyrosol in Caco-2 cells. FEBS Letters 2000, 470:341-344.
21. Marrugat J., Covas M.I., Fitó M., Schröder H., Miró-Casas E., Gimeno E., et al. Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation. A randomized controlled trial. European Journal of Nutrition 2004, 43:140-147.
22. Mateos R., Espartero J.L., Trujillo M., Ríos J.J., León-Camacho M., Alcudia F., et al. Determination of phenols, flavones, and lignans in virgin olive oils by solid-phase extraction and high-performance liquid chromatography with diode array ultraviolet detection. Journal of Agricultural and Food Chemistry 2001, 49:2185-2192.
23. Mateos R., Goya L., Bravo L. Metabolism of the olive oil phenols hydroxytyrosol, tyrosol and hydroxytyrosyl acetate by human hepatoma HepG2 cells. Journal of Agricultural and Food Chemistry 2005, 53:9897-9905.
24. Meinl W., Ebert B., Glatt H., Lampen A. Sulfotransferase forms expressed in human intestinal Caco-2 and TC7 cells at varying stages of differentiation and role in benzo[a]pyrene metabolism. Drug Metabolism and Disposition 2008, 36:276-283.
25. Miró-Casas E., Covas M.I., Farré M., Fito M., Ortuño J., Weinbrenner T., et al. Hydroxytyrosol disposition in humans. Clinical Chemistry 2003, 49:945-952.
26. Pereira-Caro, G., Bravo, L., Escuderos, M. E., Madrona, A., Trujillo, M., Cert, A., et al. (2009). In vitro availability of hydroxytyrosol, hydroxytyrosyl acetate and alkyl hydroxytyrosyl ethers. 7th Euro Fed Lipid Congress. Graz (Austria). 353.
27. Prueksaritanont T., Gorham L.M., Hochman J.H., Tran L.O., Vyas K.P. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestine, and in Caco-2 cells. Drug Metabolism and Disposition 1996, 24:634-642.
28. Romero C., Medina E., Vargas J., Brenes M., De Castro A. In vitro activity of olive oil polyphenols against Helicobacter pylori. Journal of Agricultural and Food Chemistry 2007, 55:680-686.
29. Soler A., Romero M.P., Macia A., Saha S., Furniss C.S.M., Kroon P.A., et al. Digestion stability and evaluation of the metabolism and transport of olive oil phenols in the human small-intestinal epithelial Caco-2/TC7 cell line. Food Chemistry 2010, 119:703-714.
30. Trípoli E., Giammanco M., Tabacchi G., Di Majo D. The phenolic compounds of olive oil: Structure, biological activity and beneficial effects on human health. Nutrition Research Reviews 2005, 18:98-112.
31. Tuck K.L., Hayball P.J., Stupans I. Structural characterization of the metabolites of hydroxytyrosol, the principal phenolic component in olive oil, in rats. Journal of Agricultural and Food Chemistry 2002, 50:2404-2409.
32. Visioli F., Caruso D., Grande S., Bosisio R., Villa M., Galli G., et al. Virgin olive oil study (VOLOS): Vasoprotective potencial of extra virgin olive oil in mildly dyslipidemic patients. European Journal of Nutrition 2005, 44:121-127.
33. Visioli F., Galli C., Bornet F., Mattei A., Patelli R., Galli G., et al. Olive oil phenolics are dose-dependently absorbed in humans. FEBS Letters 2000, 468:159-160.
34. Visioli F., Galli C., Grande S., Colonnelli K., Patelli C., Galli G., et al. Hydroxytyrosol excretion differs between rats and humans and depends on the vehicle of administration. Journal of Nutrition 2003, 133:2612-2615.
35. Vissers M.H., Zock P.L., Roodenburg A.J., Leenen R., Katan M.B. Olive oil phenols are absorbed in humans. Journal of Nutrition 2002, 132:409-417.
36. Weinbrenner T., Fitó M., de la Torre R., Sáez Gt., Rijken P., Tormos C., et al. Olive oils high in phenolic compounds modulate oxidative/antioxidative status in men. Journal of Nutrition 2004, 134:2314-2321.